¿Es la disección axilar dirigida una alternativa en el carcinoma oculto de mama? Descripción de un caso

IF 0.2 Q4 OBSTETRICS & GYNECOLOGY
Rebeca De la Iglesia López , Alejandra García-Novoa , Carmen Conde , Alberto Bouzón Alejandro , Benigno Acea-Nebril
{"title":"¿Es la disección axilar dirigida una alternativa en el carcinoma oculto de mama? Descripción de un caso","authors":"Rebeca De la Iglesia López ,&nbsp;Alejandra García-Novoa ,&nbsp;Carmen Conde ,&nbsp;Alberto Bouzón Alejandro ,&nbsp;Benigno Acea-Nebril","doi":"10.1016/j.senol.2024.100575","DOIUrl":null,"url":null,"abstract":"<div><p>Occult breast carcinoma is a very rare entity that is defined as the presence of axillary disease without detectable tumor in the breast. When searching for the origin of a tumor, the use of bimodal techniques such as PET/CT has become especially useful, but there is little evidence about the management of these tumors. Currently, the standard treatment is primary systemic therapy (PST), followed by axillary lymphadenectomy and radiotherapy of the breast and lymph node chains. In this case we present the possibility of treating this disease with a more conservative surgical approach: through directed axillary dissection in a patient with occult breast carcinoma, who debuted with the appearance of a single axillary adenopathy observed on tomography. After completing primary systemic therapy, a complete radiological response was confirmed and a directed axillary dissection was indicated, with evidence in the operating room of a coincidence between the sentinel lymph node and the lymph node initially biopsied. After completing the treatment with radiotherapy of the breast and lymph node chains and anti-Her2 therapy, the patient is disease-free. It seems that an axillary treatment similar to that of locally advanced breast cancer can be considered, so in limited axillary disease (N1) targeted axillary dissection associated with radiotherapy could be an alternative.</p></div>","PeriodicalId":38058,"journal":{"name":"Revista de Senologia y Patologia Mamaria","volume":"37 2","pages":"Article 100575"},"PeriodicalIF":0.2000,"publicationDate":"2024-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista de Senologia y Patologia Mamaria","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0214158224000033","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Occult breast carcinoma is a very rare entity that is defined as the presence of axillary disease without detectable tumor in the breast. When searching for the origin of a tumor, the use of bimodal techniques such as PET/CT has become especially useful, but there is little evidence about the management of these tumors. Currently, the standard treatment is primary systemic therapy (PST), followed by axillary lymphadenectomy and radiotherapy of the breast and lymph node chains. In this case we present the possibility of treating this disease with a more conservative surgical approach: through directed axillary dissection in a patient with occult breast carcinoma, who debuted with the appearance of a single axillary adenopathy observed on tomography. After completing primary systemic therapy, a complete radiological response was confirmed and a directed axillary dissection was indicated, with evidence in the operating room of a coincidence between the sentinel lymph node and the lymph node initially biopsied. After completing the treatment with radiotherapy of the breast and lymph node chains and anti-Her2 therapy, the patient is disease-free. It seems that an axillary treatment similar to that of locally advanced breast cancer can be considered, so in limited axillary disease (N1) targeted axillary dissection associated with radiotherapy could be an alternative.

腋窝靶向切除术是隐匿性乳腺癌的替代方案吗?病例报告
隐匿性乳腺癌是一种非常罕见的疾病,其定义是乳房内未发现肿瘤而存在腋窝疾病。在寻找肿瘤来源时,使用正电子发射计算机断层显像(PET/CT)等双模态技术尤为有用,但有关此类肿瘤的治疗方法却证据不足。目前,标准的治疗方法是先进行全身治疗(PST),然后进行腋窝淋巴结切除术,并对乳房和淋巴结链进行放疗。在本病例中,我们介绍了用更保守的手术方法治疗这种疾病的可能性:通过对一名隐匿性乳腺癌患者进行定向腋窝清扫,该患者因在断层扫描中观察到单个腋窝腺病而首次就诊。在完成主要的全身治疗后,患者的放射学反应得到完全证实,因此需要进行定向腋窝清扫术,在手术室有证据表明前哨淋巴结和最初活检的淋巴结是重合的。在完成乳腺和淋巴结链放疗以及抗 Her2 治疗后,患者已无疾病。看来,可以考虑采用与局部晚期乳腺癌类似的腋窝治疗方法,因此,对于局限性腋窝疾病(N1),结合放疗进行有针对性的腋窝清扫也不失为一种选择。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Revista de Senologia y Patologia Mamaria
Revista de Senologia y Patologia Mamaria Medicine-Obstetrics and Gynecology
CiteScore
0.30
自引率
0.00%
发文量
74
审稿时长
63 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信